Appropriate use of venous imaging and analysis of the D-Dimer / Clinical Probability testing paradigm in the Diagnosis and Location of Deep Venous Thrombosis.

07:00 EST 1st March 2018 | BioPortfolio

Summary of "Appropriate use of venous imaging and analysis of the D-Dimer / Clinical Probability testing paradigm in the Diagnosis and Location of Deep Venous Thrombosis."

The D-Dimer (DD) level combined with the pretest Wells criteria probability (WCP) score can safely exclude Deep Venous Thrombosis (DVT). The objective for this study was to examine the correlation between DD results alongside WCP score with findings on venous duplex ultrasound (VDU). The hypothesis is that VDU remains over utilized in low-risk patients with negative DD and that higher DD levels may correlate with thrombus burden and location.


Journal Details

This article was published in the following journal.

Name: Annals of vascular surgery
ISSN: 1615-5947


DeepDyve research library

PubMed Articles [40351 Associated PubMed Articles listed on BioPortfolio]

Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolism.

A low D-dimer can exclude suspected pulmonary embolism (PE) in cases with low or intermediate clinical probability of disease. Yet D-dimer is nonspecific, so many cases without PE require imaging. D-d...

Decision making with D-dimer in the diagnosis of pulmonary embolism.

Measurement of a D-dimer level can be a powerful tool in the diagnosis of venous thromboembolism in the right context and with the right application. Used correctly, a clinical strategy combining pret...

Diagnostic accuracy of biomarker D-dimer in patients after stroke suspected from venous thromboembolism: A diagnostic meta-analysis.

D-dimer is a promising biomarker for identification of venous thromboembolism (VTE) in patients with stroke. The purpose of our study is to evaluate the diagnostic value of D-dimer as a promising biom...

Models to Estimate the Probability of Malignancy in Patients with Pulmonary Nodules.

Pulmonary nodules (PN) are a common clinical problem. The goals of their evaluation are to expedite the diagnosis and treatment of patients with malignant nodules, and to minimize testing in patients ...

"HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?

The "HERDOO2 rule" is a prospectively validated clinical decision rule used to identify low-risk women who can safely discontinue anticoagulants after completing 5-12 months of anticoagulant treatme...

Clinical Trials [11077 Associated Clinical Trials listed on BioPortfolio]

Safety of a Diagnostic Strategy With D-Dimer Testing for PE

To determine whether D-Dimer testing, using the MDA D-Dimer assay, can be used to simplify the diagnostic process for pulmonary embolism (PE). This will be assessed by performing a cohort...

D-Dimer Guided Oral Anticoagulant Treatment (OAT)

This clinical trial will investigate the hypothesis that D-Dimer testing can be successfully used to tailor the duration of OAT in patients after an unprovoked episode of deep venous throm...

D-Dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism

Optimal duration of oral anticoagulant therapy in patients with recurrent episodes of venous thromboembolism (VTE) is a matter of debate and recommendations are based on inadequate evidenc...

ThRombosis ExclUsion STudy

The purpose of this study is to demonstrate the ability of new D-Dimer assay combined with a clinical pretest probability (PTP) to safely exclude pulmonary embolism (PE) or Deep Venous Thr...

Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)

The main objective of the trial is to determine whether D-dimer testing combined with assessment of Pre-Test-Probability (using a standardized clinical model) can be used to markedly simpl...

Medical and Biotech [MESH] Definitions

A theorem in probability theory named for Thomas Bayes (1702-1761). In epidemiology, it is used to obtain the probability of disease in a group of people with some characteristic on the basis of the overall rate of that disease and of the likelihoods of that characteristic in healthy and diseased individuals. The most familiar application is in clinical decision analysis where it is used for estimating the probability of a particular diagnosis given the appearance of some symptoms or test result.

Laboratory testing and diagnostic imaging services offered to consumers outside of the patient-physician relationship.

Impaired venous blood flow or venous return (venous stasis), usually caused by inadequate venous valves. Venous insufficiency often occurs in the legs, and is associated with EDEMA and sometimes with VENOUS STASIS ULCERS at the ankle.

The use of molecularly targeted imaging probes to localize and/or monitor biochemical and cellular processes via various imaging modalities that include RADIONUCLIDE IMAGING; ULTRASONOGRAPHY; MAGNETIC RESONANCE IMAGING; fluorescence imaging; and MICROSCOPY.

The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.

Quick Search


DeepDyve research library

Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...

Searches Linking to this Article